Pharma Marketing Network

APRIL 3, 2025

The Digital Transformation of Patient Marketing Technology has revolutionized how pharma communicates with patients. These tools help pharma brands deliver HIPAA-compliant, personalized content to segmented audiences based on health behavior and condition. How has patient marketing changed in recent years?

HIPAA 52

HIPAA Communication Packaging Pharmaceutical Companies 52

Pharma Marketing Network

FEBRUARY 5, 2025

Compliance Challenges and How to Overcome Them Pharma marketing on social media comes with strict regulations , including: FDA and EMA guidelines restricting direct-to-consumer advertising. HIPAA and GDPR laws protecting patient privacy. This approach makes content more engaging, shareable, and relatable for patients.

HIPAA 52

HIPAA Communication FDA 52

Pharma Marketing Network

JANUARY 9, 2025

Clearly communicating the benefits and risks of drugs like Keytruda establishes credibility and trust. Adhering to regulations like GDPR and HIPAA ensures your campaigns are both ethical and secure. Regulatory Compliance: Marketing teams must stay updated on guidelines from the FDA, EMA, and other regulatory bodies.

HIPAA 52

HIPAA Communication FDA 52

Pharma Marketing Network

JANUARY 7, 2025

Navigating HIPAA regulations while tailoring messages requires careful planning and ethical decision-making. From updated FDA guidelines to stricter European regulations, keeping up with these changes is critical. For marketing executives, the challenge lies in balancing personalization with compliance.

HIPAA 52

HIPAA Pharmaceutical Companies Pharmaceutical Companies FDA 52

Pharma Marketing Network

JANUARY 9, 2025

Automation: Email marketing and CRM tools streamline communication, saving time while maintaining personalization. FDA and EMA Updates: Regularly monitor guidelines from agencies like the FDA (U.S.) Following GDPR and HIPAA guidelines safeguards both your company and your audience.

HIPAA 52

HIPAA Process Improvement FDA Communication 52

Pharma Marketing Network

DECEMBER 19, 2024

Solution: Partner with legal and compliance teams to ensure all campaigns adhere to FDA and HIPAA guidelines. Clearly communicate data usage policies to build trust. Use automated tools to flag non-compliant content before publication.

HIPAA 52

HIPAA Communication FDA 52

Pharma Marketing Network

APRIL 10, 2025

Similarly, healthcare providers expect personalized, timely communications that complement their clinical priorities. It means using data responsibly to tailor content, recommend resources, and support adherenceall while complying with HIPAA and other healthcare regulations. Compliance remains essential in paid campaigns.

HIPAA 52

HIPAA Communication FDA 52

pharmaphorum

DECEMBER 13, 2022

This precipitated a shift from a centralised trial experience to a decentralised one, resulting in participants communicating electronically. Both the EMA and FDA have released draft guidance on the issue and are currently soliciting feedback. BYOD in clinical trials. Statistics show there are 6.5

Data Entry 59

Data Entry HIPAA Insurance Communication 59

ISPE

OCTOBER 27, 2022

Given the public health emergency, health authorities offered greater flexibilities in the use of digital health platforms and technologies such as: Enhanced HIPAA (Health Insurance Portability and Accountability Act of 1996) flexibilities in the use of telemedicine services 3. Wireless medical devices.

Health and Personal Care Stores 52

Health and Personal Care Stores FDA HIPAA Communication 52

ISPE

OCTOBER 27, 2022

In December 2021, the US FDA issued a cross-center draft guidance with recommendations on the use of digital health technology tools (DHTTs) to acquire data remotely from participants in clinical investigations for medical products. Wireless medical devices.

Health and Personal Care Stores 52

Health and Personal Care Stores FDA Communication Clinic Management 52